IP Library Patent Application 17941061
Patent Application
App. No. 17/941,061

PIPERIDINE DERIVATIVES AND COMPOSITIONS FOR THE INHIBITION OF NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE (NAMPT)

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/941,061
Abstract

The present invention relates to compounds and compositions for the inhibition of NAMPT, their synthesis, applications and antidotes. An illustrative compound of the invention is shown below: Formula (I)

Claims (29)

1 - 28 . (canceled)

29 . A compound of Formula IB:

or a pharmaceutically acceptable salt thereof, wherein:

R is an aryl, heteroaryl, C 3 -C 8 cycloalkyl, C 3 -C 8 cycloalkenyl, heterocycloalkyl, arylalkyl-, (heteroaryl)alkyl-, (C 3 -C 8 cycloalkyl)alkyl-, (C 3 -C 8 cycloalkenyl)alkyl-, (heterocycloalkyl)alkyl-, (aryloxy)alkyl-, (heteroaryloxy)alkyl-, (C 3 -C 8 cycloalkyloxy)alkyl-, (C 3 -C 8 cycloalkenyloxy)alkyl- or (heterocycloalkyloxy)alkyl-, wherein the heteroatom of each of said heteroaryl and heterocycloalkyl numbers 1, 2 or 3, and is independently selected from N, S or O, further wherein each of said aryl, heteroaryl and heterocycloalkyl may independently be either substituted or fused with an aryl or heteroaryl, still further wherein any of said aryl, heteroaryl and heterocycloalkyl is optionally substituted with one or more substituents which can be the same or different and are independently selected from the group consisting of deuterium, halo, cyano, amino, aminoalkyl-, (amino)alkoxy-, —CONH 2 , —C(O)NH(alkyl), —C(O)N(alkyl) 2 , —C(O)NH(aryl), —C(O)N(aryl) 2 , —CH z F 3-z , —OCH z F 3-z , -alkyl, -alkenyl, -alkynyl, -alkoxy, hydroxyl, alkyl hydroxy, hydroxyl, alkyl hydroxy, or (alkoxyalkyl) amino-, —N(R 3 )—C(O)-alkyl, —N(R 3 )—C(O)-aryl, -cycloalkyl, -heterocycloalkyl, -aryl, and heteroaryl, with the proviso that no two adjacent ring heteroatoms are both S or both O;

G is aryl, heteroaryl, cycloalkyl, heterocycloalkyl, with each of said aryl, heteroaryl, heterocycloalkyl and cycloalkyl being optionally substituted with 1, 2, 3 or 4 substituents which can be the same or different and are independently selected from the group consisting of deuterium, halo, cyano, amino, aminoalkyl-, (amino)alkoxy-, —CONH 2 , —C(O)NH(alkyl), —C(O)N(alkyl) 2 , —C(O)NH(aryl), —C(O)N(aryl) 2 , —CH z F 3-z , —OCH z F 3-z , -alkyl, -alkenyl, -alkynyl, -alkoxy, hydroxyl, -alkyl hydroxyl, aryloxy-, (alkoxyalkyl)amino-, —N(R 3 )—C(O)-alkyl, —N(R 3 )—C(O)-aryl, -cycloalkyl, -heterocycloalkyl, -aryl, and -heteroaryl;

R 3 is H, alkyl or arylalkyl-;

A is aryl, heteroaryl, heterocycloalkyl or C 3 to Cs cycloalkyl, with each of said aryl, heteroaryl, heterocycloalkyl and cycloalkyl being optionally substituted with 1, 2, 3 or 4 substituents which can be the same or different and are independently selected from the group consisting of deuterium, halo, cyano, amino, aminoalkyl-, (amino)alkoxy-, —CONH 2 , —C(O)NH(alkyl), —C(O)N(alkyl) 2 , —C(O)NH(aryl), —C(O)N(aryl) 2 , —CH z F 3-z , —OCH z F 3-z , -alkyl, -alkenyl, -alkynyl, -alkoxy, hydroxyl, -alkyl hydroxyl, aryloxy-, (alkoxyalkyl)amino-, —N(R 3 )—C(O)-alkyl, —N(R 3 )—C(O)-aryl, -cycloalkyl, -heterocycloalkyl, -aryl, and -heteroaryl;

Q is C(O), S(O), S(O) 2 , or —CH 2 —C(O);

n is 0, 1, 2, 3, 4, 5 or 6; and

z is 0, 1 or 2.

30 . The compound of claim 29 , wherein R is heteroaryl.

31 . The compound of claim 29 , wherein R is (heteroaryl)alkyl.

32 . The compound of claim 29 , wherein A is heterocycloalkyl.

33 . The compound of claim 29 , wherein A is aryl.

34 . The compound of claim 29 , wherein Q is S(O) 2 .

35 . The compound of claim 29 , wherein G is optionally substituted heteroaryl.

36 . The compound of claim 29 , wherein G is optionally substituted aryl.

37 . The compound of claim 30 , wherein A is heterocycloalkyl.

38 . The compound of claim 37 , wherein Q is S(O) 2 .

39 . The compound of claim 38 , wherein G is optionally substituted heteroaryl.

40 . The compound of claim 38 , wherein G is optionally substituted aryl.

41 . The compound of claim 31 , wherein A is aryl.

42 . The compound of claim 41 , wherein Q is S(O) 2 .

43 . The compound of claim 42 , wherein G is optionally substituted heteroaryl.

44 . The compound of claim 42 , wherein G is optionally substituted aryl.

45 . The compound of claim 43 , wherein n is 0.

46 . The compound of claim 31 , wherein R is (heteroaryl)alkyl, and alkyl is straight or branched.

47 . The compound of claim 31 , wherein R is (heteroaryl)alkyl, and alkyl is cyclized.

48 . The compound of claim 31 , wherein R is (pyridinyl)alkyl.

Assignments (2)
RELEASE OF SECURITY INTEREST Recorded Oct 17, 2023
From: FIRST-CITIZENS BANK & TRUST COMPANY, AS AGENT
To: VALO HEALTH, INC.; VALO HEALTH, LLC
Reel/Frame 065255/0660 →
SECURITY INTEREST Recorded Jul 6, 2023
From: VALO HEALTH, LLC; VALO HEALTH, INC.
To: FIRST-CITIZENS BANK & TRUST COMPANY, AS AGENT
Reel/Frame 064207/0957 →